Omada Health, Inc. ( (OMDA) ) has released its Q3 earnings. Here is a breakdown of the information Omada Health, Inc. presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Omada Health, Inc. is a virtual healthcare provider focusing on cardiometabolic and musculoskeletal conditions, leveraging AI technology to deliver personalized care. In its third quarter of 2025, Omada Health reported significant financial growth, with a 49% increase in revenue to $68 million and a 53% rise in total membership compared to the previous year. The company also achieved its first quarter of positive adjusted EBITDA, marking a notable reduction in net loss from $9 million to $3 million.
Key highlights from the quarter include the announcement of a new prescribing offering that integrates behavior change programs with medication management for anti-obesity medications, including GLP-1s. Omada also launched ‘Meal Map,’ an AI-powered nutrition tool, and published its 30th peer-reviewed manuscript, showcasing cost savings and sustained weight maintenance post-GLP-1 therapy.
Financially, Omada Health improved its gross margin to 66% and reported a non-GAAP gross margin of 68%. The company ended the quarter with $199 million in cash and cash equivalents, reflecting a strong financial position. The strategic initiatives and financial performance underscore Omada’s commitment to innovation and cost-effective healthcare solutions.
Looking ahead, Omada Health projects its 2025 revenue to range between $251.5 million and $254.5 million, with an adjusted EBITDA outlook from a $2 million loss to breakeven. The company continues to focus on expanding its offerings and enhancing its AI capabilities to drive sustainable outcomes and growth.